Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the...

19
JASON GLASER Co-founder and CEO of La Isla Foundation

Transcript of Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the...

Page 1: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

JASON GLASERCo-founder and CEO of La Isla Foundation

Page 2: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

13,000 PEOPLE DIED OF EBOLA SINCE IT EMERGED IN 1976

Page 3: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

CURRENTLY WE’RE EXAMINING ANOTHER GLOBAL EPIDEMIC

Page 4: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

JUST IN CENTRAL AMERICA 20,000 PEOPLE HAVE DIED IN THE LAST 10 YEARS

Page 5: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

TRADITIONAL VICTIM OF CKD

Page 6: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

UP TO 42% OF THE WORKERS IN SOME COMMUNITIES HAVE CKDNT

Page 7: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

THE DISEASE DISPROPORTIONALLY IMPACTS SUGARCANE CUTTERS

Page 8: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

CKDNT FOR WORKERS SHOULD BE VIEWED AS A DEATH SENTENCE

Page 9: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

WITHOUT PROTECTION THE DISEASE CAN DEVELOP OVER ONE HARVEST

Page 10: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

A MOBILE TENT WITH SHADE AND EACH WORKER HAS A CAMELBAK

Page 11: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

AN IMPROVED ERGONOMIC MACHETE

Page 12: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

MORE EFFICIENT CANE CUTTING AND LOADING

Page 13: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

THE RESULTS ARE VERY POSITIVE

Page 14: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

DOUBLEDwater intake

Page 15: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

NO MOREheat strokes

Page 16: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

HALTEDdecline kidney function

Page 17: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

40%more productivity

Page 18: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

WHICH SUGAR BUYER WILL BE THE NEXT SUPPORTER?

Page 19: Jason Glaser, CEO La Isla Foundation Nicaragua, about research on and likely solutions for the epidemic of CKDnT in Central America.

SUGARCANE,FUEL FOR CHANGE